📰 GeneralTechCrunchWednesday, October 14, 2026 at 11:00 PM UTC1h ago

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology

Read full article at TechCrunch →

Originally published by TechCrunch. Summary and curation by DutyStation News.

← Back to News

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

📰 Related Stories

Gudea leverages AI to help organizations prevent social media crises before they erupt

Economist breaks down new inflation report and what's driving prices higher - PBS

McKinsey is making job applicants spar with a fake AI client

Jim Cramer explains why even strong bank earnings couldn't save their stocks

Jim Cramer says don't give up on this unpredictable market. Here's why

YouTube begins rolling out GIF support for comments very slowly; it’s for a reason